New ways to diagnose inflammatory lung diseases
Part of Lungs & breathing clinical trials.
This study is testing new diagnostic methods for people with COPD, IPF, or combined pulmonary fibrosis and emphysema. It involves collecting blood and saliva samples and using monitoring devices to better understand these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a diagnosis of COPD, IPF, or combined pulmonary fibrosis and emphysema.
- You must be willing to provide blood and saliva samples for research.
- You must be willing to use monitoring devices and attend follow-up visits.
- You must be able to give written informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different stages of COPD and how they relate to traditional Chinese medicine patterns. It collects health information and samples to better understand the disease, which might help improve future treatments.
This study looks at different forms of COPD to find better ways to treat them. It may help you understand your own condition and receive more personalized care.
This study collects airway samples (usually during a bronchoscopy), plus blood and/or urine, to help researchers study lung conditions. It may help advance understanding of lung disease and related biology, but it is not a treatment trial.
This trial is studying people with chronic lung conditions, like COPD or asthma, to find treatable traits. It also includes healthy volunteers for comparison, to better understand what makes these diseases different and how to personalize treatment.
This study looks at how the immune system works and how well diseases like asthma, COPD, and others are controlled. You may join if you have one of these conditions or if you are a healthy volunteer or smoker without lung disease.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
Hear when a new Idiopathic Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.